NO20004523L - Avleveringssystem for Õ modulere immunrespons - Google Patents

Avleveringssystem for Õ modulere immunrespons

Info

Publication number
NO20004523L
NO20004523L NO20004523A NO20004523A NO20004523L NO 20004523 L NO20004523 L NO 20004523L NO 20004523 A NO20004523 A NO 20004523A NO 20004523 A NO20004523 A NO 20004523A NO 20004523 L NO20004523 L NO 20004523L
Authority
NO
Norway
Prior art keywords
immune response
delivery system
modulating immune
modulating
delivery
Prior art date
Application number
NO20004523A
Other languages
English (en)
Other versions
NO20004523D0 (no
Inventor
Roberto L Rivera
Original Assignee
Allergenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergenics Inc filed Critical Allergenics Inc
Publication of NO20004523D0 publication Critical patent/NO20004523D0/no
Publication of NO20004523L publication Critical patent/NO20004523L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20004523A 1998-03-12 2000-09-11 Avleveringssystem for Õ modulere immunrespons NO20004523L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/041,514 US6328967B1 (en) 1998-03-12 1998-03-12 Delivery system to modulate immune response
PCT/US1999/005128 WO1999045904A1 (en) 1998-03-12 1999-03-09 Delivery system to modulate immune response

Publications (2)

Publication Number Publication Date
NO20004523D0 NO20004523D0 (no) 2000-09-11
NO20004523L true NO20004523L (no) 2000-11-03

Family

ID=21916921

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004523A NO20004523L (no) 1998-03-12 2000-09-11 Avleveringssystem for Õ modulere immunrespons

Country Status (10)

Country Link
US (2) US6328967B1 (no)
EP (1) EP1061903A1 (no)
JP (1) JP2002506019A (no)
CN (1) CN1292686A (no)
AU (1) AU748882B2 (no)
CA (1) CA2322472A1 (no)
NO (1) NO20004523L (no)
NZ (1) NZ506479A (no)
PL (1) PL342936A1 (no)
WO (1) WO1999045904A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
PE20000601A1 (es) 1998-03-23 2000-07-25 Gen Mills Inc Encapsulado de componentes en productos comestibles
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
CA2376045A1 (en) 1999-07-22 2001-02-01 The Procter & Gamble Company Subtilisin protease variants having amino acid substitutions in defined epitope regions
BR0012694A (pt) 1999-07-22 2002-04-09 Procter & Gamble Conjugado de protease, composição de limpeza e composição de tratamento pessoal
KR20020021397A (ko) 1999-07-22 2002-03-20 데이비드 엠 모이어 규정된 에피토프 영역에 아미노산 결실 및 치환을 갖는서브틸리신 프로테아제 변이체
AU783099B2 (en) * 2000-01-07 2005-09-22 Rohm Gmbh & Co. Kg Selective activation of a TH1 or TH2 lymphocyte regulated immune response
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
CN1469737A (zh) * 2000-10-16 2004-01-21 ��һ��������ҩ��ʽ���� 口腔内快速崩解的药用组合物及其制备方法
JP4499991B2 (ja) * 2001-04-02 2010-07-14 ジェネンコー・インターナショナル・インク 粉塵生成の潜在性が減少した顆粒
US8076113B2 (en) 2001-04-02 2011-12-13 Danisco Us Inc. Method for producing granules with reduced dust potential comprising an antifoam agent
CA2466982A1 (en) 2001-11-19 2003-05-30 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
US20040043070A1 (en) * 2002-05-14 2004-03-04 Ayres James W. Hot melt coating by direct blending and coated substrates
KR100530369B1 (ko) * 2002-05-27 2005-11-22 이영환 항암물질에 나노입자를 결합시킨 주사 제형의 약물 시스템
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
US20070141071A1 (en) * 2003-05-14 2007-06-21 Oregon State University Hot melt coating by direct blending and coated substrates
BRPI0512210A (pt) * 2004-06-18 2008-02-19 Unilever Nv composição, composição farmacêutica, composição cosmética, alimento, e, método para produzir uma camada contìnua de uma pluralidade de cristais de sal
DE602005020880D1 (de) * 2004-10-14 2010-06-10 Unilever Nv Verfahren zum Kristallwachstum
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007112747A1 (en) * 2006-03-31 2007-10-11 Curalogic A/S Immunogen combinations
MX2010002249A (es) * 2007-08-31 2010-03-17 Amgen Inc Formulacion de proteina de estado solido.
CH701350A1 (it) * 2009-06-24 2010-12-31 Artcell Invest Ltd Metodo per il trattamento dell'arterosclerosi.
EP2515661A4 (en) * 2009-12-23 2013-11-13 Vaxgene Corp IMMUNE PROTECTION THROUGH ORAL ADMINISTRATION OF MINI-CAPSULES WITH RECOMBINANT LACTOCOCCUS LACTIS
ES2644138T3 (es) 2011-06-13 2017-11-27 Rival S.E.C N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
EP4323548A4 (en) * 2021-04-13 2025-05-21 Illumina Cambridge Limited Compositions, systems and methods for making and using encapsulated lyophilized microspheres

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1037792A (en) * 1964-03-13 1966-08-03 Konditerskaja Fabrika Im Marat Enteric coated oral vaccines for intestinal infections
US5417986A (en) * 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
JPH07116057B2 (ja) 1988-05-11 1995-12-13 理化学研究所 免疫増強剤及び強化抗原
ES2109362T3 (es) * 1991-06-21 1998-01-16 Univ Cincinnati Unas proteinas administrables oralmente y metodo para hacerlas.
SG52402A1 (en) 1992-12-22 1998-09-28 Univ Cincinnati Oral administration of immunologically active biomolecules and other therapeutic proteins
WO1994023738A1 (en) 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
FR2723849B1 (fr) 1994-08-31 1997-04-11 Biovector Therapeutics Sa Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique

Also Published As

Publication number Publication date
JP2002506019A (ja) 2002-02-26
NZ506479A (en) 2004-12-24
NO20004523D0 (no) 2000-09-11
EP1061903A1 (en) 2000-12-27
PL342936A1 (en) 2001-07-16
CA2322472A1 (en) 1999-09-16
AU2993099A (en) 1999-09-27
US6328967B1 (en) 2001-12-11
CN1292686A (zh) 2001-04-25
US20020034514A1 (en) 2002-03-21
WO1999045904A1 (en) 1999-09-16
AU748882B2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
NO20004523D0 (no) Avleveringssystem for Õ modulere immunresponsen
DE69711045D1 (de) Vitamin c abgabesystem
NO972093D0 (no) Pumpesystem
DE19882536T1 (de) Doppelpumpenanlage
DE69822529D1 (de) Stentanbringungssystem
NL1003571A1 (nl) Pompstelsel.
DE69821928D1 (de) Intrakardiales defibrillierungssystem
ID21702A (id) Sistim dispenser
DE69832055D1 (de) Transdermales abgabesystem
DE69816858D1 (de) Beatmungssystem
DE69836715D1 (de) Nachrichtenübertragungssystem
ID26105A (id) Sistem transaksi
DE69801983D1 (de) Verbindungssystem
ID23428A (id) Stabilisator uv untuk sistem siloksan
DE69915677D1 (de) Vordrucksystem
DE69734043D1 (de) Parfümfreisetzungssystem
DE59811803D1 (de) Kommunikationssystem
NO20016377D0 (no) Forbedret strömningsfordelingssystem
NO981995D0 (no) Horisontalpumpesystem
DE19782185T1 (de) Pumpensystem
DE69411018D1 (de) Komponentenzulieferungsanlage
DE59802576D1 (de) Schienenfahrzeugsystem
DE69818391D1 (de) Nebenabflusssystem
FI974143A7 (fi) Liitäntäjärjestelmä lämmityslaitteita varten
DE69811604D1 (de) Förderanlage

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application